Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Mar 08 2023

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-08-2023-3

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 08, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Prazosin Hydrochloride Capsules USP, 1 mg, 2 mg, and 5 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases